Avantax Advisory Services’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-940
| Closed | -$18K | – | 1392 |
|
|
2022
Q1 | $18K | Buy |
940
+320
| +52% | +$6.13K | ﹤0.01% | 1272 |
|
|
2021
Q4 | $11K | Sell |
620
-400
| -39% | -$7.1K | ﹤0.01% | 1240 |
|
|
2021
Q3 | $38K | Sell |
1,020
-20
| -2% | -$745 | ﹤0.01% | 1165 |
|
|
2021
Q2 | $62K | Hold |
1,040
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q1 | $69K | Buy |
1,040
+520
| +100% | +$34.5K | ﹤0.01% | 1010 |
|
|
2020
Q4 | $31K | Sell |
520
-216
| -29% | -$12.9K | ﹤0.01% | 926 |
|
|
2020
Q3 | $59K | Buy |
736
+316
| +75% | +$25.3K | ﹤0.01% | 1333 |
|
|
2020
Q2 | $26K | Buy |
420
+160
| +62% | +$9.91K | ﹤0.01% | 841 |
|
|
2020
Q1 | $14K | Hold |
260
| – | – | ﹤0.01% | 792 |
|
|
2019
Q4 | $31K | Hold |
260
| – | – | ﹤0.01% | 814 |
|
|
2019
Q3 | $48K | Hold |
260
| – | – | ﹤0.01% | 560 |
|
|
2019
Q2 | $34K | Buy |
+260
| New | +$34K | ﹤0.01% | 511 |
|